Previously, we found that a divalent format of an AffiDC, (ZHER2:2891)2-ABD-mcDM1, was able to slow tumor growth and as a consequence increase survival of mice with implanted HER2-overexpressing SKOV3 tumors [13]. Here, ERBB2 is linked to neoplasm.